Low penetrance, subclinical congenital LQTS: Concealed LQTS or silent LQTS?

Cardiovascular Research

Volumn 70, Issue 3, 2006, Pages 404-406

  Varró, Andras ^a   Papp, Julius Gy ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ1;

EDITORIAL; ELECTROCARDIOGRAM; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SEX RATIO; SYNCOPE; TACHYCARDIA; TORSADE DES POINTES;

ADULT; DOWN-REGULATION; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MUTATION; MYOCARDIUM; PENETRANCE; TORSADES DE POINTES;

EID: 33747466843     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.04.006     Document Type: Editorial

References (18)

1. Boulet I.R., Raes A.L., Ottschytsch N., and Snyders D.J. Functional effects of a KCNQ1 mutation associated with the long QT syndrome. Cardiovasc Res 70 (2006) 466-474
2. Chen S., Zhang L., Bryant R.M., Vincent G.M., Flippin M., Lee J.C., et al. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death. Clin Genet 63 (2003) 273-282
3. Camm A.J., Malik M., and Yap Y.G. Measurement of QT interval and repolarization assessment. Acquired long QT syndrome (2004), Blackwell/Futura, London 24-59
4. Kass R.S., and Moss A.J. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest 112 (2003) 810-815
5. Roden D.M. Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med 259 (2006) 59-69
6. Roden D.M. Taking the idio out of idiosyncratic-predicting torsade de pointes. Pacing Clin Electrophysiol 21 (1998) 1029-1034
7. Roden D.M., and Yang T. Protecting the heart against arrhythmias: potassium current physiology and repolarization. Circulation 112 (2005) 1376-1378
8. Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S., Robinson J.L., et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1 and KCNE2. Circulation 102 (2000) 1178-1185
9. Ks activation through interactions with Isk. Cardiovasc Res 45 (2000) 971-980
10. Gouas L., Bellocq C., Berthet M., Potet F., Demolombe S., Forhan A., et al. New KCNQ1 mutations leading to haploinsufficiency in a general population. Defective trafficking of a KvLQT1 mutant. Cardiovasc Res 63 (2004) 60-68
11. Huang L., Bitner-Glindzicz M., Tranebj?rg L., and Tinker A. A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res 51 (2001) 670-680
12. Ackerman M.J. Genotype-phenotype relationship in congenital long QT syndrome. J Electrocardiol 38 (2005) 64-68
13. Tamargo J., Caballero R., Gomez R., Valenzuela C., and Delpon E. Pharmacology of cardiac potassium channels. Cardiovasc Res 62 (2004) 9-33
14. Ks) in canine ventricular myocytes. J Physiol 551.3 (2003) 777-786
15. Jost N., Virág L., Bitay M., Takács J., Lengyel Cs., Biliczki P., et al. Restricting excessive cardiac action potential and QT prolongation. Circulation 112 (2005) 1392-1399
16. Ks in dog ventricular muscle and Purkinje fibre repolarization. J Physiol 523.1 (2000) 67-81
17. Kääb S., Hinterseer M., Näbauer M., and Steinbeck G. Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome-a case-control pilot study using i.v. sotalol. Eur Heart J 24 (2003) 649-657
18. Ehrlich J.R., Pourrier M., Weerapura M., Ethier N., Marmabachi A.M., Hébert T.E., et al. KvLQT1 modulates the distribution and biophysical properties of HERG. J Biol Chem 279 (2004) 1233-1241